Leukemia Articles A-Z
Acute leukemia is cancer that starts in blood-forming tissue and progresses very quickly. As explained in this eMedTV article, there are two main types of acute leukemia: acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML).
Acute lymphocytic leukemia accounts for about 3,800 new cases of leukemia each year. This section of the eMedTV archives describes acute lymphocytic leukemia, which is the most common type of leukemia in young children but can also affect adults.
Acute Lymphocytic Leukemia Death Statistics
Acute lymphocytic leukemia death statistics show that the highest number of deaths is in people under 20 years old; the lowest number is in people over age 85. This eMedTV article provides additional acute lymphocytic leukemia death statistics.
Acute Lymphocytic Leukemia Statistics
Acute lymphocytic leukemia statistics show that the overall 5-year relative survival rate was 64.6 percent. This page of the eMedTV website includes more acute lymphocytic leukemia statistics about the incidence, lifetime risk, and death rates.
Acute Myeloid Leukemia Statistics
Acute myeloid leukemia statistics show that 1 in 250 men and women born today will be diagnosed with acute myeloid leukemia. This page of the eMedTV website lists acute myeloid leukemia statistics about the incidence, death rates, and lifetime rates.
Adult Acute Lymphoblastic Leukemia
Adult acute lymphoblastic leukemia (also known as ALL) accounts for about 3,800 new cases of leukemia each year. This eMedTV article discusses the risk factors, symptoms, stages, and treatments of adult acute lymphoblastic leukemia.
Adult acute myeloid leukemia is a type of cancer in which the bone marrow makes abnormal myeloblasts, red blood cells, or platelets. This eMedTV article describes adult acute myeloid leukemia, which affected an estimated 11,960 people in 2005.
Current adult ALL treatment options can include chemotherapy and radiation therapy. This page of the eMedTV website describes adult ALL treatment, including the two phases of treatment, which are remission induction therapy and maintenance therapy.